Non-enzymatic glycosylation

British Medical Bulletin

Volumn 45, Issue 1, 1989, Pages 174-190

  Kennedy, L ^a   Lyons, T J ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN;

DIABETES MELLITUS; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; BLOOD PROTEINS; DIABETES MELLITUS; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; TIME FACTORS;

EID: 0024540829     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a072310     Document Type: Article

References (51)

1. Maillard LC Action des acides amines sur les sucres: formation des melanoid-înes par voie méthodique. CR Seances Acad Sei [2I] 1912; 154. 66-68
2. Allen DW, Schroeder WA, Balog J. Observations on the chromatographic heterogeneity of normal adult and fetal hemoglobin J Am Chem Soc 1958; 80 1628-1634
3. Huisman THJ, Dozy AM Studies on the heterogeneity of hemoglobin V Binding of hemoglobin with oxidized glutathione. J Lab Clin Med 1962; 60 302-319
4. Rahbar S An abnormal hemoglobm in red cells of diabetes Clin Chim Acta 1968, 22: 296-298
5. Rahbar S, Blumenfeld O, Ranney HM Studies on an unusual hemoglobin in patients with diabetes mellitus Biochem Biophys Res Commun 1969, 36: 838-843
6. Tnvelli LA, Ranney HM, Lai H-T. Hemoglobm components m patients with diabetes mellitus N Engl J Med 1971; 284 353-357
7. Fluckiger R, Winterhalter KH In vitro synthesis of haemoglobin Alc FEBS Lett 1976; 71: 356-360
8. Bookchin RM, Gallop PM. Structure of hemoglobm Alc nature of the N-terminal chain blocking group. Biochem Biophys Res Commun 1968, 32: 86-93
9. Bunn HF, Haney DN, Gabbay KH et al Further identification of the nature of linkage of the carbohydrate in hemoglobm Alc Biochem Biophys Res Commun 1975, 67 103-109
10. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobm Alc m diabetes mellitus N Engl J Med 1976, 295: 417-420
11. Goldstern DE, Peth SB, England JD, Hess RL, DaCosta J Effects of acute changes in blood glucose on HbAlc. Diabetes 1980; 29 623-628
12. Kennedy L Labile glycosylated haemoglobin-is it clinically important? Diabetic Med 1985, 2. 86-87
13. Nathan DM, Smger DE, Hurxthal K, Goodson JD The clinical information value of the glycosylated hemoglobm assay. N Engl J Med 1984; 310 341-346
14. Kennedy L, Byrne E, Savage G, Merrett JD. Routine measurement of haemoglobin A, at the diabetic outpatient clinic. Ulster Med J 1984; 53: 51-57
15. Schleicher ED, Gerbitz KD, Dolhofer R et al. Clinical utility of nonenzymau-cally glycosylated blood proteins as an index of glucose control. Diabetes Care 1984; 7: 548-556
16. Holman RR, Turner RC. Maintenance of basal plasma glucose and insulin concentrations m maturity onset diabetes. Diabetes 1979; 28. 227-230
17. Holman RR, Turner RC The basal plasma glucose a simple relevant index of maturity onset diabetes Clm Endocrinol 1980, 14 279-286
18. McCance DR, Ritchie CM, Kennedy L Is hemoglobin A, superfluous in non-msulin-dependent diabetes mellitus Diabetes Care 1988, 11 512-514
19. UK Prospective Diabetes Study of Therapies of Maturity Onset Diabetes 1 Effect of diet, sulphonylurea, insulin or biguamde therapy on fastmg plasma glucose and body weight over one year. Multi-centre study Diabetologia 1983, 24 404-411
20. Pecoraro RE, Koepsell TD, Chen MS, Lipsky BA, Belcher DW, Inui TS. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin m non-msulm-dependent diabetes mellitus. Diabetes Care 1986; 9: 37-375
21. Goldstern DE, Walker B, Rawlmgs SS et al Hemoglobin A, c levels in children and adolescents with diabetes mellitus Diabetes Care 1980, 3: 503-507
22. Dahlquist G, Blom L, Bohne P et al Metabolic control in 131 juvenile-onset diabetic patients as measured by HbAlc: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections Diabetes Care 1982, 5: 399-403
23. Boucher BJ, Burrm JM, Gould BJ et al. A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom. Diabetologia 1983; 24. 265-271
24. Goldstein DE, Parker KM, England JD et al Clinical application of glycosylated hemoglobin measurements. Diabetes 1982; 31 (Suppl 3) 70-78
25. Dolhofer R, Wieland OH Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients FEBS Lett 1979, 103. 282-286
26. Kennedy L, Mehl TD, Riley WJ, Menmee TJ Nonenzymatically glycosylated serum protein in diabetes mellitus an index of short-term glycaemia Diabetologia 1981, 21 94-98
27. Elder E, Kennedy L. Improved rapid assay of nonenzymatically glycosylated serum proteins following hydrolysis in an autoclave Diabetologia 1983; 24 70
28. Gould BJ, Hall PM, Cooke JGH. A sensitive method for the measurement of glycosylated plasma proteins using affinity chromatography. Ann Clin Biochem 1984, 21 16-21
29. Johnson RN, Metcalf PA, Baker JR. Fructosamine a new approach to the estimation of serum glycosylprotetn An index of diabetic control Clm Chim Acta 1982, 127 87-95
30. Lloyd DR, Non M, Marples J. Comparison of serum fructosamine with glycosylated serum protein (determined by affinity chromatography) for the assessment of diabetic control Diabetic Med 1985, 2 474-478
31. McCance DR, Coulter D, Smye M, Kennedy L Effect of fluctuations in albumin on serum fructosamine. Diabetic Med 1987, 4 434-436
32. Fluckiger R, Woodtli T, Berger W Evaluation of the fructosamine test for the measurement of plasma protein glycation Diabetologia 1987, 30 648-652
33. Hindle EJ, Rostron GM, Gatt JA The estimation of serum fructosamine an alternative measurement to glycated haemoglobin Ann Clin Biochem 1985; 22 84-89
34. Baker JR, Johnson RN, Scott DJ. Serum fructosamine concentrations in pauents with Type 2 (non-insuhn-dependent) diabetes mellitus during changes in management. Br Med J 1984, 288: 1484-1486
35. Curtiss LK, Witztum JL Plasma apolipoproteins AI, All, B, Cl and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985, 34 452-461
36. Sasaki J, Cottam GL. Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 1982; 713: 199-207
37. Lopes-Virella MF, Sherer GK, Lees AM et al Surface binding, internalisation and degradation by cultured human fibroblasts of low density lipoproteins isolated from Type I (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 1982; 22 430-436
38. Steinbrecher UP, Witztum JL. Glucosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984, 33. 130-134
39. Lyons TJ, Klenin RL, Baynes JW, Stevenson HC, Lopes-Virclla MF. Stimulation of cholesteryl ester synthesis in human monocyte-denved macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients, the influence of nonenzymatic glycosylation of low-density lipoproteins Diabetologia 1987, 30: 916-923
40. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL Glucosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-denved macrophages. Diabetes 1988; 37: 550-557
41. Kent MJC, Light ND, Bailey AJ. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro Biochem J 1985; 225 745-752
42. Schmder SL, Kohn RR The effects of age and diabetes mellitus on the solubility and non-enzymatic glucosylanon of human skin collagen. J Clin Invest 1981; 67:1630-1635
43. Yue DK, McLennan S, Delbndge L, Handelsman DJ, Reeve T, Turtle JR The thermal stability of collagen in diabetic rats correlation with seventy of diabetes and non-enzymatic glycosylation. Diabetologia 1983, 24: 282-285
44. Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited joint mobility m childhood diabetes mellitus indicates increased risk for microvascular disease N Engl J Med 1981, 305 191-194
45. Bcacom R, Gillespie E, Middleton D, Sawhney B, Kennedy L Limited joint mobility in insulin-dependent diabetes: relationship to retinopathy, penpheral nerve function and HLA status Q J Med 1985; 56: 337-344
46. Lyons TJ, Kennedy L. Non-enzymatic glycosylation of skin collagen m patients with Type 1 (insulin-dependent) diabetes mellitus and limited joint mobility. Diabetologia 1985; 28. 2-5
47. Monmer VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn R Relation between complications of Type 1 diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986, 314 403-408
48. Ponger S, Ulrich PC, Bencsath A, Cerami A Ageing of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypepndes with glucose. Proc Natl Acad Sa 1984, 81 2684-1688
49. Chang JCF, Ulnch PC, Bucala R, Cerami A Detection of an advanced glycosylation product bound to protein in situ. J Biol Chem 1985; 260. 7970-7974
50. Ahmed MU, Thorpe SR, Baynes JW. Identificanon of N-carboxymethyllysine as a degradanon product of fructosclysine m glycated protein. J Biol Chem 1986; 261:4889-1894
51. Brownlee M, Vlassara H, Klooney A, Ulnch P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Saence 1986; 232:1629-1632